Globally, more than one billion people suffer from arterial hypertension (AH), 80% in countries with a socio-economic background and developing countries. The AH prevalence in 2015 was estimated at 1.13 billion population, which increases proportionally with age, up to 60 years old constituting 30-40%, and over 75 years over 70%, up to 55 years more common in males. According to the European AH Management Guidelines ESC/ESH 2018 it is estimated that in people with AH it will be increased to 15-20% by 2025, reaching almost 1.5 billion. Patient Y, 70 years old. Diagnosis: Arterial Hypertension II degree, very high additional risk, st. III. Ischemic heart disease. Angina pectoris FC II. Complete left bundle branch block. HF III NYHA. Dyslipidemia. clinical: constrictive retrosternal pain lasting 5 minutes, depending on moderate physical effort, breathless breathing at rest, headache, scotoma. Family health history is worsened, smoker. Physical exam: rhythmic heart beats, HB 80 b/min., blood pressure – 165/90 mmHg. Investigation: ECG: sinusal rhythm, HB 80 b/min., complete left bundle branch block. EcoCG: hypertrophy of left ventricle. Biochemical analysis: dyslipidemia, hyperuricemia. Treatment including: lifestyle changes, control of risk factors, antihypertensive treatment to achieve the target values. In all ethnic groups, men have higher mean systolic and diastolic blood pressure as compared to women, and through middle age hypertension is more prevalent in men as compared to women. Arterial Hypertension in men can be influenced by the most common risk factors: smoking, alcohol abuse of salt, dyslipidemia, hyperuricemia, stress. Men have elevated serum uric acid levels as compared to women. Men are at greater risk for sleep-related disorders that may contribute to the pathogenesis of hypertension. It is important to diagnose such disorders because effective treatment may improve blood pressure control. Periodic monitoring of blood pressure and low compliance to treatment frequently leads to complications: coronary heart disease, acute coronary syndrome, stroke, angio and neuropathies.